Further work is also needed to characterise the phenotype and function of the proliferating PI33‐63‐specific CD4+ T cells, and to map changes in progressors and non‐progressors to T1D, and in individuals with sustained remission in clinical trials of immunotherapy. The gene discussed is CD4; the disease is type 1 diabetes mellitus.